HomeSVNS • LON
add
Solvonis Therapeutics PLC
Previous close
GBX 0.25
Day range
GBX 0.24 - GBX 0.28
Year range
GBX 0.11 - GBX 0.40
Market cap
18.86M GBP
Avg Volume
37.59M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 808.50K | 197.24% |
Net income | -810.50K | -158.95% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.72M | 6,266.67% |
Total assets | 9.54M | 346.24% |
Total liabilities | 2.61M | 439.26% |
Total equity | 6.94M | — |
Shares outstanding | 5.91B | — |
Price to book | ∞ | — |
Return on assets | -21.18% | — |
Return on capital | -28.83% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -810.50K | -158.95% |
Cash from operations | -507.00K | -139.72% |
Cash from investing | 4.00K | 147.06% |
Cash from financing | 985.50K | 531.73% |
Net change in cash | 481.00K | 851.56% |
Free cash flow | -410.06K | -159.53% |
About
Founded
2017
Website
Employees
3
